| Autor: |
Hongkai Bao, Yi Guo, Mei H. Chang, Terrence McSweeney, Austin M. Golia, Kelsie Cowman, Rachel Bartash, Brenda I. Anosike, Priya Nori |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022) |
| Druh dokumentu: |
article |
| ISSN: |
2732-494X |
| DOI: |
10.1017/ash.2022.52 |
| Popis: |
Antimicrobial stewardship programs (ASPs) can be expanded to the outpatient setting to serve as a first line of defense against coronavirus disease 19 (COVID-19) hospitalizations and to reduce the burden on emergency departments and acute-care hospitals. Given the numerous emergency use authorizations of monoclonal antibodies and oral antivirals, ASPs possess the expertise and leadership to direct ambulatory COVID-19 initiatives and transform it into a predominantly outpatient illness. In this review, we summarize the critical role and benefits of an ASP-championed ambulatory COVID-19 therapeutics program. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
